Quick Takeaways
- TCG Crossover GP I, LLC filed SCHEDULE 13G for Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share (TYRA).
- Disclosed ownership: 5.7%.
- Date of event: 27 Feb 2025.
TCG Crossover GP I, LLC - 27 Feb 2025 SCHEDULE 13G Report for Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share (TYRA)
- Filing Manager
- TCG Crossover GP I, LLC
- Reporting Manager
- TCG Crossover GP I, LLC
- Symbol
- TYRA
- Shares outstanding
- 50,843,912 shares
- Disclosed Ownership
- 2,898,103 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Mar 2025, 18:02:17 UTC
- Date of event
- 27 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"TCG Crossover GP I, LLC disclosed 5.7% ownership in Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share (TYRA) on 27 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Mar 2025, 18:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TCG Crossover GP I, LLC | 5.7% | 2,898,103 | 0 | 2,898,103 | /s/ Craig Skaling | Authorized Signatory | |
| TCG Crossover Fund I, L.P. | 5.7% | 2,898,103 | 0 | 2,898,103 | /s/ Craig Skaling | Authorized Signatory | |
| Chen Yu | 5.7% | 2,898,103 | 0 | 2,898,103 | /s/ Craig Skaling | By POA as Attorney-in-Fact |